Fluidigm Corp. Reaches New 12-Month High at $24.48 (FLDM)
Fluidigm Corp. (NASDAQ:FLDM)’s share price reached a new 52-week high during trading hours on Thursday, AnalystRatingsNetwork reports. The company traded as high as $24.48 and last traded at $23.87, with a volume of 163,094 shares traded. The stock had previously closed at $22.82.
Several analysts have recently commented on the stock. Analysts at Zacks upgraded shares of Fluidigm Corp. from a “neutral” rating to an “outperform” rating in a research note to investors on Tuesday, October 8th. They now have a $23.60 price target on the stock. Separately, analysts at Cowen and Company raised their price target on shares of Fluidigm Corp. from $20.00 to $24.00 in a research note to investors on Monday, August 12th. They now have an “outperform” rating on the stock. Finally, analysts at Cantor Fitzgerald raised their price target on shares of Fluidigm Corp. from $22.00 to $23.00 in a research note to investors on Friday, August 2nd. They now have a “buy” rating on the stock. Two analysts have rated the stock with a hold rating and four have issued a buy rating to the company’s stock. The stock currently has a consensus rating of “Buy” and an average target price of $22.52.
Fluidigm Corp. has a 1-year low of $13.43 and a 1-year high of $23.39. The stock’s 50-day moving average is $21.96 and its 200-day moving average is $18.90. The company’s market cap is $610.4 million.
Fluidigm Corp. (NASDAQ:FLDM) last issued its quarterly earnings data on Thursday, August 1st. The company reported ($0.07) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.17) by $0.10. The company had revenue of $17.50 million for the quarter, compared to the consensus estimate of $15.87 million. During the same quarter in the previous year, the company posted ($0.13) earnings per share. The company’s revenue for the quarter was up 35.7% on a year-over-year basis. Analysts expect that Fluidigm Corp. will post $-0.65 EPS for the current fiscal year.
Fluidigm Corporation (NASDAQ:FLDM) develops, manufactures and markets microfluidic systems such as single-cell genomics, applied genotyping and sample preparation for targeted resequencing, in the life science and agricultural biotechnology, or Ag-Bio, industries.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.